These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 11939866

  • 1. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
    Hypericum Depression Trial Study Group, Davidson JR, Gadde KM, Fairbank JA, Krishnan KRR, Califf RM, Binanay C, Parker CB, Pugh N, Hartwell TD, Vitiello B, Ritz L, Severe J, Cole JO, de Battista C, Doraiswamy PM, Feighner JP, Keck P, Kelsey J, Lin KM, Londborg PD, Nemeroff CB, Schatzberg AF, Sheehan DV, Srivastava RK, Taylor L, Trivedi MH, Weisler RH.
    JAMA; 2002 Apr 10; 287(14):1807-14. PubMed ID: 11939866
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of St John's wort in major depression: a randomized controlled trial.
    Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U.
    JAMA; 2001 Apr 18; 285(15):1978-86. PubMed ID: 11308434
    [Abstract] [Full Text] [Related]

  • 3. St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT.
    Sarris J, Fava M, Schweitzer I, Mischoulon D.
    Pharmacopsychiatry; 2012 Nov 18; 45(7):275-8. PubMed ID: 22592504
    [Abstract] [Full Text] [Related]

  • 4. The impact of missing data on clinical trials: a re-analysis of a placebo controlled trial of Hypericum perforatum (St Johns wort) and sertraline in major depressive disorder.
    Grobler AC, Matthews G, Molenberghs G.
    Psychopharmacology (Berl); 2014 May 18; 231(9):1987-99. PubMed ID: 24232445
    [Abstract] [Full Text] [Related]

  • 5. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
    Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M.
    BMC Med; 2006 Jun 23; 4():14. PubMed ID: 16796730
    [Abstract] [Full Text] [Related]

  • 6. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
    Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF.
    J Clin Psychopharmacol; 2005 Oct 23; 25(5):441-7. PubMed ID: 16160619
    [Abstract] [Full Text] [Related]

  • 7. Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.
    Bitran S, Farabaugh AH, Ameral VE, LaRocca RA, Clain AJ, Fava M, Mischoulon D.
    Int Clin Psychopharmacol; 2011 Jul 23; 26(4):206-12. PubMed ID: 21278577
    [Abstract] [Full Text] [Related]

  • 8. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH, Lin SH, Jang FL.
    J Clin Psychopharmacol; 2011 Oct 23; 31(5):563-8. PubMed ID: 21869699
    [Abstract] [Full Text] [Related]

  • 9. Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial.
    Weber W, Vander Stoep A, McCarty RL, Weiss NS, Biederman J, McClellan J.
    JAMA; 2008 Jun 11; 299(22):2633-41. PubMed ID: 18544723
    [Abstract] [Full Text] [Related]

  • 10. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
    Mannel M, Kuhn U, Schmidt U, Ploch M, Murck H.
    J Psychiatr Res; 2010 Sep 11; 44(12):760-7. PubMed ID: 20181361
    [Abstract] [Full Text] [Related]

  • 11. Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial.
    Vitiello B, Shader RI, Parker CB, Ritz L, Harlan W, Greenblatt DJ, Gadde KM, Krishnan KR, Davidson JR.
    J Clin Psychopharmacol; 2005 Jun 11; 25(3):243-9. PubMed ID: 15876903
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y, Clerc G, Didi R, Kieser M.
    Am J Psychiatry; 2002 Aug 11; 159(8):1361-6. PubMed ID: 12153829
    [Abstract] [Full Text] [Related]

  • 13. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
    Gelenberg AJ, Shelton RC, Crits-Christoph P, Keller MB, Dunner DL, Hirschfeld RM, Thase ME, Russell JM, Lydiard RB, Gallop RJ, Todd L, Hellerstein DJ, Goodnick PJ, Keitner GI, Stahl SM, Halbreich U, Hopkins HS.
    J Clin Psychiatry; 2004 Aug 11; 65(8):1114-9. PubMed ID: 15323598
    [Abstract] [Full Text] [Related]

  • 14. St John's wort or sertraline? Randomized controlled trial in primary care.
    van Gurp G, Meterissian GB, Haiek LN, McCusker J, Bellavance F.
    Can Fam Physician; 2002 May 11; 48():905-12. PubMed ID: 12053635
    [Abstract] [Full Text] [Related]

  • 15. Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
    Solomon D, Adams J, Graves N.
    J Affect Disord; 2013 Jun 11; 148(2-3):228-34. PubMed ID: 23291009
    [Abstract] [Full Text] [Related]

  • 16. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov 11; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.
    Canning S, Waterman M, Orsi N, Ayres J, Simpson N, Dye L.
    CNS Drugs; 2010 Mar 11; 24(3):207-25. PubMed ID: 20155996
    [Abstract] [Full Text] [Related]

  • 18. Sertraline treatment of major depression in patients with acute MI or unstable angina.
    Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, Mclvor M, Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group.
    JAMA; 2002 Aug 14; 288(6):701-9. PubMed ID: 12169073
    [Abstract] [Full Text] [Related]

  • 19. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun 14; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 20. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
    Brenner R, Azbel V, Madhusoodanan S, Pawlowska M.
    Clin Ther; 2000 Apr 14; 22(4):411-9. PubMed ID: 10823363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.